Article Text

Download PDFPDF
Authors’ response
  1. Elisabetta Bugianesi1,
  2. Gianluca Svegliati-Baroni2,
  3. Giulio Marchesini3
  1. 1
    Division of Gastroenterology, University of Turin, Italy
  2. 2
    Department of Gastroenterology, Polytechnic University of Marche, Ancona, Italy
  3. 3
    Unit of Metabolic Diseases, “Alma Mater” University of Bologna, Italy
  1. Dr Elisabetta Bugianesi, Division of Gastro-Hepatology, S. Giovanni Battista Hospital, Corso Bramante 88, 10126 Turin, Italy; ebugianesi{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

We wish to thank Dr Nobili and Dr Targher for their comments concerning our recent paper (Gut 2007;56:1296–301), as this gives us the opportunity to clarify a few aspects of insulin sensitivity/resistance and the different physiological meanings of HOMA-R and OGIS. The euglycaemic hyperinsulinaemic glucose clamp measures insulin sensitivity (IS) as the ability of insulin to lower blood glucose levels by stimulating glucose uptake (mainly in the muscle). When comparing the clamp with other surrogate methods of IS, it is important to understand whether the index is based on similar principles, and correlation coefficients with the clamp are not sufficient to judge their validity.1

HOMA-R is calculated in the fasting state, thus reflecting the ability of basal insulin to suppress …

View Full Text

Linked Articles